SUPPLEMENT
Q1 2022 — Income statement trends
Q1 2022PDF · 2 pages140 KB
CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q120 Q220 Q320 Q420 Q121 Q221 Q321 Q421 Q122 Revenues: Clearing and transaction fees 1,278.8 940.2 835.4 843.0 1,007.0 929.9 878.9 949.3 1,138.1 Market data and information services 131.5 134.7 139.4 139.8 144.2 145.2 145.4 142.1 151.7 Other Revenue 111.8 107.4 105.9 115.7 102.1 104.1 85.6 55.9 56.8 Total revenues 1,522.1 1,182.3 1,080.7 1,098.5 1,253.3 1,179.2 1,109.9 1,147.3 1,346.6 Expenses: Compensation and benefits 207.5 217.0 216.4 215.6 225.0 211.7 198.6 201.7 185.2 Technology 47.7 49.1 48.1 53.6 48.2 49.3 49.3 45.8 45.9 Professional fees and outside services 41.7 51.2 48.4 50.0 37.4 36.8 45.2 32.3 31.8 Amortization of purchased intangibles 77.3 76.6 78.3 79.0 60.6 59.4 59.0 58.6 58.4 Depreciation and amortization 35.3 36.7 39.7 41.5 37.6 37.1 37.2 35.9 33.5 Licensing and other fee agreements 73.9 55.4 57.7 57.9 64.7 54.2 57.6 60.4 80.9 Other expense 78.8 58.8 67.1 85.9 54.7 56.0 49.3 80.9 51.8 Operating expenses 562.2 544.8 555.7 583.5 528.2 504.5 496.2 515.6 487.5 Operating Income 959.9 637.5 525.0 515.0 725.1 674.7 613.7 631.7 859.1 Operating Margin 63% 54% 49% 47% 58% 57% 55% 55% 64% Non-operating Income and Expense Investment income 95.9 32.1 23.6 31.1 30.9 62.4 145.8 67.8 73.1 Interest and other borrowing costs (40.9) (41.9) (41.7) (41.7) (41.5) (41.7) (41.8) (41.9) (42.5) Equity in net gains (losses) of unconsolidated subsidiaries 51.2 48.8 44.0 46.6 56.2 55.7 66.4 67.5 73.3 Other non-operating income (expense) (76.8) (15.2) (14.4) (16.0) (18.4) (25.0) 311.8 74.2 (46.7) Non-operating income (expense) 29.4 23.8 11.5 20.0 27.2 51.4 482.2 167.6 57.2 Income before income taxes 989.3 661.3 536.5 535.0 752.3 726.1 1,095.9 799.3 916.3 Income taxes 222.5 158.0 125.0 110.2 177.5 215.5 169.6 174.1 205.3 Net income 766.8 503.3 411.5 424.8 574.8 510.6 926.3 625.2 711.0 Less: net income (loss) attributable to NCI 0.6 - (0.2) 0.8 0.4 0.3 (0.2) - - Net Income Attributable to CME Group 766.2 503.3 411.7 424.0 574.4 510.3 926.5 625.2 711.0 Net Income Attributable to CME Group 766.2 503.3 411.7 424.0 574.4 510.3 926.5 613.3 702.0 Effective Tax Rate 22.5% 23.9% 23.3% 20.6% 23.6% 29.7% 15.5% 21.8% 22.4% Earnings per Share: Basic EPS 2.14 1.41 1.15 1.18 1.60 1.42 2.59 1.71 1.96 Diluted EPS 2.14 1.40 1.15 1.18 1.60 1.42 2.58 1.71 1.95 Weighted average number of common stock shares: Basic Shares 357,524 357,691 357,791 358,047 358,147 358,261 358,363 358,582 358,609 Diluted Shares 358,455 358,457 358,590 358,612 358,817 358,888 358,988 359,019 359,180 Preferred Shares 2,890 4,584 -- 1 of 2 -- CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF NON-GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q120 Q220 Q320 Q420 Q121 Q221 Q321 Q421 Q122 Revenues: Clearing and transaction fees 1,278.8 940.2 835.4 843.0 1,007.0 929.9 878.9 949.3 1,138.1 Market data and information services 131.5 134.7 139.4 139.8 144.2 145.2 145.4 142.1 151.7 Other Revenue 111.8 107.4 105.9 115.7 102.1 101.0 85.6 55.9 56.8 Total revenues 1,522.1 1,182.3 1,080.7 1,098.5 1,253.3 1,176.1 1,109.9 1,147.3 1,346.6 Expenses: Compensation and benefits 210.9 202.7 205.5 202.6 207.5 201.9 191.1 183.7 182.8 Technology 47.3 48.5 47.3 52.2 47.7 49.2 49.1 45.6 45.8 Professional fees and outside services 35.3 42.7 40.0 39.2 27.9 30.0 26.5 27.2 30.3 Amortization of purchased intangibles - - - - - - - - - Depreciation and amortization 34.5 33.7 37.0 37.2 36.8 36.7 36.7 35.6 33.5 Licensing and other fee agreements 73.9 55.4 57.7 57.9 64.7 54.2 57.6 60.4 80.9 Other expense 57.6 51.9 56.1 74.3 52.1 54.8 51.3 76.5 51.7 Operating expenses 459.5 434.9 443.6 463.4 436.7 426.8 412.3 429.0 425.0 Operating Income 1,062.6 747.4 637.1 635.1 816.6 749.3 697.6 718.3 921.6 Operating Margin 70% 63% 59% 58% 65% 64% 63% 63% 68% Non-operating Income and Expense Investment income 102.3 26.4 22.6 24.1 26.9 37.3 55.1 58.2 74.7 Interest and other borrowing costs (42.6) (41.9) (41.7) (41.7) (41.5) (41.7) (41.8) (41.9) (42.5) Equity in net gains (losses) of unconsolidated subsidiaries 51.2 48.8 44.0 46.6 56.2 55.7 70.5 78.7 84.7 Other non-operating income (expense) (78.3) (15.2) (14.4) (16.0) (18.4) (25.0) (32.9) (33.0) (43.4) Non-operating income (expense) 32.6 18.1 10.5 13.0 23.2 26.3 50.9 62.0 73.5 Income before income taxes 1,095.2 765.5 647.6 648.1 839.8 775.6 748.5 780.3 995.1 Income taxes 258.8 182.3 152.8 150.2 198.2 186.7 174.3 172.8 228.9 Net income 836.4 583.2 494.8 497.9 641.6 588.9 574.2 607.5 766.2 Less: net income (loss) attributable to NCI 0.6 - (0.2) 0.8 0.4 0.3 (0.2) - - Net Income Attributable to CME Group 835.8 583.2 495.0 497.1 641.2 588.6 574.4 607.5 766.2 Net Income Attributable to Common Shareholders of CME Group 835.8 583.2 495.0 497.1 641.2 588.6 574.4 595.7 756.6 Effective Tax Rate 23.6% 23.8% 23.6% 23.2% 23.6% 24.1% 23.3% 22.1% 23.0% Earnings per Share: Basic EPS 2.34 1.63 1.38 1.39 1.79 1.64 1.60 1.66 2.11 Diluted EPS 2.33 1.63 1.38 1.39 1.79 1.64 1.60 1.66 2.11 Weighted average number of common stock shares: Basic Shares 357,524 357,691 357,791 358,047 358,147 358,261 358,363 358,582 358,609 Diluted Shares 358,455 358,457 358,590 358,612 358,817 358,888 358,988 359,019 359,180 Preferred Shares - - - - - - - 2,890 4,584 -- 2 of 2 --